Join our free newsletter for some exclusive info we don’t share elsewhere.
John Paulson’s Paulson & Co. was dumping gold heading into 2015, right before the massive rally. Such is Paulson’s luck of late. Paulson has been a gold bug for years now.
Paulson had over 5% of his portfolio in the GLD heading into the fourth quarter but sold off close to 40% of that position before 2016. Poor timing.
Other picks of Paulson heading into 2016 include adding 50% to his Valeant Pharma (VRX) bet – now no. 3 largest holding. Allergan (AGN) remains his biggest bet – owning 1.4% of the company. AGN is down 9% YTD. Other top 5 picks by Paulson include Shire (SHPG), Teva (TEVA) and Mylan (MYL) – all down over 15% YTD.